Re-dosing of prostaglandin-E 1 versus prostaglandin-E 1 plus phentolamine in male erectile dysfunction: a dynamic color power Doppler study
In terms of the recommendations of the varied committees of the 1st International consultation on Erectile Dysfunction, organized by the WHO from July 1 ± 3, 1999 in Paris, the paper`Re-dosing of prostaglandin E 1 versus prostaglandin E 1 plus phentolamine in male erectile dysfunction: a dynamic color power Doppler study' 1 must be considered antiquated with no bene®cial effect on the management of male impotence.
At this Consensus Conference, in which nearly all renowned experts participated, it was in general agreement that such complicated studies as presented in this series should not be considered and recommended as a routinely diagnostic work-up in erectile dysfunction. Moreover in terms of diagnostic requirements for evaluation of male impotence most of the participating experts reduced their recommendations to only medical and sexual history combined with physical examination and then followed by a so-called`Viagra 1 -test' at home without anticipating pharmacotesting and vascular assessment.
I personally do not agree to such a more or less diagnostic nihilism as in my experience more than 70% of the males and especially of the female partners would like to know something about the underlying etiology in order to understand the reason for the compromised sexual life. This knowledge cannot be provided by a`Viagra 1 -test' at home as it is proven that this test Ð by the way it is not a diagnostic test but a therapeutic approach Ð cannot differentiate among psychogenic or organic causes of erectile dysfunction. Therefore it seems reasonable that all these patients with the desire to understand the etiology of their erectile failure should undergo reduced laboratory examinations, including serum glucose, testosterone and prolactin as well as a pharmacotesting with PGE 1 or the trimix-combination combined with doppler or duplexsonography of the penile arteries. With this diagnostic approach the most important organic causes for erectile dysfunction may be ruled out and the patient can be counselled in an adequate way in terms of possible risk factors. For this purpose pharmacotesting with a single dosage of a vasoactive drug or combination is suf®cient in order to prove or exclude obviously penile arterial problems. In terms of the proof of so-called venoocclusive dysfunction redosing with or without visual sexual stimulation is not able to prove reliably the maximal cavernosal relaxation capacity due to the increased sympathetic tone, encountered in many patients and resulting in false negative results.
A personal comparative study in more than 600 patients provided convincing evidence that in terms of proof of veno-occlusive integrity a Viagra 1 -test at home leads to more reliable ®ndings than any high dosage of vasoactive drugs or than redosing in inof®ce testing. Moreover this redosing with VSS is quite expensive and time-consuming and does not at all represent a goal directed approach to the problem. The same statement is applicable for the described improvement of color doppler imaging with illustration of helicine arterioles and their rami®cations. What will be the therapeutic answer to this high-technically vascular assessment? I guess oral or intracavernosal drug-therapy in dependence of the individual risk-pro®le. And to rule out obvious vascular pathology a simple duplex-or color doppler-sonography represents a reliable and economical diagnostic method. Therefore as impressive and exciting this dynamic color power doppler study is in the era of new oral and intracavernosal or intraurethral drug-therapy this diagnostic approach must be considered uneconomical and non goal directed.
Finally the policy of the authors to interrupt prolonged erections after 2 h with intracavernosal injection of metaraminol is not only inconclusive but hazardous and life-threatening for the patients as with this drug several cases with severe hypertensive crisis followed by cerebrovascular complications and lethal outcome were described in the literature. 2, 3 As it is proven that only priapisms of more than 12 h duration may result in irreversible ultra-structural changes of cavernosal tissue in rare single cases 4 there is no need to interrupt erections after 2 h and especially with such a dangerous drug like metaraminol. If there is a need for interruption of a true priapism what is per de®nition after 6 h the case than safer sympathomimetic agonists like etilefrine or phenylephrine must be applied as it was repeatedly described in the literature. 5 
Reply to HC Porst
Even in the Viagra 1 era up to 50% of patients with erectile dysfunction (ED) do not respond to sildena®l treatment. 1 More severe is the organic cause and more likely sildena®l therapy lacks of ef®cacy. Thus, as it is also outlined in the editorial comment, in patients with ED the diagnostic nihilism should be avoided and a careful diagnostic search for the ethiology of ED should be performed. Porst comments that re-dosing is not necessary and that pharmacotesting with a single dosage of a vasoactive drug or combination is suf®cient. However, re-dosing with PGE 1 during color doppler and evaluation of helicine arterioles by color power doppler (CPD) sonography are both recognized procedures to allow the best evaluation of penile circulation in ED. 2, 3 In this study, we investigated more than 100 patients and clearly showed that redosing of PGE 1 plus phentolamine followed by audiovisual sexual stimulation markedly improved the diagnostic ef®cacy of dynamic color doppler studies. Also the morphological evaluation of helicine arterioles by CPD studies led us to demonstrate that the greatest is the arteriolar damage the least is the erectile response to re-dosing of PGE 1 alone and PGE 1 plus phentolamine. In our experience these patients are also poor responders to Viagra 1 and studies are in progress aimed to correlate the degree of arteriolar damage with the response to sildena®l treatment. Therefore, it is our ®rm belief that in patients with ED an accurate diagnostic evaluation is not an antiquated procedure and is critical for the goal directed therapeutic approach; studies aimed to improve the diagnostic sensitivity should be encouraged. Prolonged erection is known to cause local acidosis, hypoxia and early ultrastructural changes, and it is established that its reversal is promptly obtained the soonest it is performed. 4 For these reasons after pharmacotesting we in general adopt a conservative approach which consists in the interruption of prolonged and often painful erection after 2 h with sympathomimetic agonists; we agree that etilephrine or phenylephrine are safer and should be used instead of metharaminol when available.
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